These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11583874)

  • 1. The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost.
    Goldman L; Phillips KA; Coxson P; Goldman PA; Williams L; Hunink MG; Weinstein MC
    J Am Coll Cardiol; 2001 Oct; 38(4):1012-7. PubMed ID: 11583874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond.
    Tice JA; Ross E; Coxson PG; Rosenberg I; Weinstein MC; Hunink MG; Goldman PA; Williams L; Goldman L
    JAMA; 2001 Aug 22-29; 286(8):936-43. PubMed ID: 11509058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China.
    Moran A; Zhao D; Gu D; Coxson P; Chen CS; Cheng J; Liu J; He J; Goldman L
    BMC Public Health; 2008 Nov; 8():394. PubMed ID: 19036167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.
    Weinstein MC; Coxson PG; Williams LW; Pass TM; Stason WB; Goldman L
    Am J Public Health; 1987 Nov; 77(11):1417-26. PubMed ID: 3661794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.
    Hamilton VH; Racicot FE; Zowall H; Coupal L; Grover SA
    JAMA; 1995 Apr; 273(13):1032-8. PubMed ID: 7897787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent overweight and future adult coronary heart disease.
    Bibbins-Domingo K; Coxson P; Pletcher MJ; Lightwood J; Goldman L
    N Engl J Med; 2007 Dec; 357(23):2371-9. PubMed ID: 18057339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact and cost-effectiveness of smoking interventions.
    Tsevat J
    Am J Med; 1992 Jul; 93(1A):43S-47S. PubMed ID: 1497003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease attributable to passive smoking: CHD Policy Model.
    Lightwood JM; Coxson PG; Bibbins-Domingo K; Williams LW; Goldman L
    Am J Prev Med; 2009 Jan; 36(1):13-20. PubMed ID: 19095162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.
    Rubinstein A; Elorriaga N; Garay OU; Poggio R; Caporale J; Matta MG; Augustovski F; Pichon-Riviere A; Mozaffarian D
    Bull World Health Organ; 2015 Sep; 93(9):614-22. PubMed ID: 26478625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health and economic benefits of increased beta-blocker use following myocardial infarction.
    Phillips KA; Shlipak MG; Coxson P; Heidenreich PA; Hunink MG; Goldman PA; Williams LW; Weinstein MC; Goldman L
    JAMA; 2000 Dec; 284(21):2748-54. PubMed ID: 11105180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness perspectives in coronary heart disease.
    Goldman L
    Am Heart J; 1990 Mar; 119(3 Pt 2):733-9; discussion 739-40. PubMed ID: 1968700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying options for reducing coronary heart disease mortality by 2020.
    Huffman MD; Lloyd-Jones DM; Ning H; Labarthe DR; Guzman Castillo M; O'Flaherty M; Ford ES; Capewell S
    Circulation; 2013 Jun; 127(25):2477-84. PubMed ID: 23661723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.
    Capewell S; Morrison CE; McMurray JJ
    Heart; 1999 Apr; 81(4):380-6. PubMed ID: 10092564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
    BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.
    Unal B; Critchley JA; Capewell S
    BMJ; 2005 Sep; 331(7517):614. PubMed ID: 16107431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.
    Pletcher MJ; Lazar L; Bibbins-Domingo K; Moran A; Rodondi N; Coxson P; Lightwood J; Williams L; Goldman L
    Ann Intern Med; 2009 Feb; 150(4):243-54. PubMed ID: 19221376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we be measuring blood cholesterol levels in young adults?
    Hulley SB; Newman TB; Grady D; Garber AM; Baron RB; Browner WS
    JAMA; 1993 Mar; 269(11):1416-9. PubMed ID: 8441219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk.
    McNeil JJ; Peeters A; Liew D; Lim S; Vos T
    J Cardiovasc Risk; 2001 Feb; 8(1):31-7. PubMed ID: 11234724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.